<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03426319</url>
  </required_header>
  <id_info>
    <org_study_id>CV-CORT-AI</org_study_id>
    <nct_id>NCT03426319</nct_id>
  </id_info>
  <brief_title>Cardiovascular Status in Adrenal Insufficiency</brief_title>
  <acronym>CVCORT-AI</acronym>
  <official_title>Cardiovascular Status in Patients With Chronic Cortisol Deficiency (Adrenal Insufficiency)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuerzburg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wuerzburg University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Within this trial, the cardiovascular status and metabolic profile of patients with chronic
      primary adrenal insufficiency is evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An unfavorable metabolic profile in patients with adrenal insufficiency (AI) under hormone
      replacement therapy with hydrocortisone (HC) has been revealed in one recent analysis.
      Furthermore an increased cardiovascular (CV) morbidity in AI is assumed. The aim of the study
      is to evaluate the metabolic profile and cardiovascular status in patients with primary AI.
      Patients with primary AI under standard replacement therapy with HC undergo detailed CV
      evaluation (including e.g. laboratory test, analysis of endothelial function, 24h blood
      pressure profile, Holter ECG, echocardiography and cardiac MRI).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular status - anamnesis</measure>
    <time_frame>12 months</time_frame>
    <description>Evaluation of the cardiovascular status of patients with chronic adrenal insufficiency by anamnesis/documentation of cardiovascular risk factors. Prevalence of cardiovascular risk factors (diabetes, hypertension, hyperlipidemia, obesity) in participating patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - mean systolic blood pressure</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of the systolic resting blood pressure (in mmHg). Analysis of the mean systolic blood pressure (of all participating patients) and the number of patients with increased systolic blood pressure (&gt;140 mmHg).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - mean diastolic blood pressure</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of the diastolic resting blood pressure (in mmHg). Analysis of the mean diastolic blood pressure (of all participating patients).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - mean BMI</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of weight (in kg) and height (qm); weight and height will be combined to report the Body Mass Index/BMI (kg/qm).
Analysis of the mean BMI (of all participating patients) and the number of patients with increased BMI (&gt;25 kg/qm).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - mean HbA1c</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of HbA1c-values (in %). Analysis of the mean HbA1c-value and the number of patients with increased HbA1c (&gt;6.5%).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - mean cholesterol-level</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of cholesterol-levels (in mg/dl). Analysis of the mean cholesterol-level and the number of patients with increased cholesterol-levels (&gt;200mg/dl).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - mean triglyceride-level</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of triglyceride-levels (in mg/dl). Analysis of the mean triglyceride-level and the number of patients with increased triglyceride-levels (&gt;200mg/dl).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - reactive hyperaemia index</measure>
    <time_frame>12 months</time_frame>
    <description>Evaluation of the reactive hyperaemia index (endothelial function). Analysis of the number of patients with a pathological reactive hyperaemia index (pathological results ≤ 1.67).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - mean systolic blood pressure (24h blood pressure measurement)</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of the mean systolic blood pressure (in mmHg) by 24h blood pressure profiles. Analysis of the mean systolic blood pressure (of all participating patients) and the number of patients with an increased mean systolic blood pressure (&gt;140 mmHg).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - non-dipper-profiles</measure>
    <time_frame>12 months</time_frame>
    <description>Documentation of the number of patients with a non-dipper-profile during a 24h blood pressure measurement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - mean ejection fraction</measure>
    <time_frame>12 months</time_frame>
    <description>Analysis of the mean ejection fraction (in %) (by echocardiography of all participating patients) and the number of patients with a pathologic ejection fraction (&lt;55%).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - diastolic function</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of the diastolic function by echocardiography. Analysis of the number of patients with a pathological diastolic function (E/A ratio; values &lt;1 were rated as pathological).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular status - pathological cardiac MRI</measure>
    <time_frame>12 months</time_frame>
    <description>Number of patients with pathological results (ejection fraction (&lt;55%), pericardial effusion, thrombus, adipose tissue, perfusion defects, late enhancement, valvular or wall motion abnormalities).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">68</enrollment>
  <condition>Adrenal Insufficiency</condition>
  <arm_group>
    <arm_group_label>Primary adrenal insufficiency</arm_group_label>
    <description>Patients with primary adrenal insufficiency on hormone replacement therapy with hydrocortisone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiovascular evaluation</intervention_name>
    <description>Cardiovascular evaluation includes anamnesis, physical examination, laboratory tests, analysis of endothelial function, 24h blood pressure profile, Holter ECG, echocardiography and cardiac MRI.</description>
    <arm_group_label>Primary adrenal insufficiency</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic primary adrenal insufficiency
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic primary adrenal insufficiency

          -  Adequate hormone replacement therapy (&gt;3 years)

          -  Age &gt;18 years

          -  Patient's informed consent

        Exclusion Criteria:

          -  Hormone replacement therapy with an other glucocorticoid than hydrocortisone

          -  Pharmacotherapy with glucocorticoids

          -  Congenital adrenal hyperplasia

          -  Coronary heart disease

          -  Heart failure

          -  Systemic disease with (potential) cardiac involvement (e.g. amyloidosis, lung
             fibrosis)

          -  Pregnancy

          -  Chronic alcohol abuse

          -  Malignant disease

          -  Arterial hypertension

          -  Chronic renal failure (MDRD &lt;60)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Wuerzburg</name>
      <address>
        <city>Wuerzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab. 2006 Dec;91(12):4849-53. Epub 2006 Sep 12.</citation>
    <PMID>16968806</PMID>
  </reference>
  <reference>
    <citation>Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab. 2009 Dec;94(12):4882-90. doi: 10.1210/jc.2009-1368. Epub 2009 Oct 26.</citation>
    <PMID>19858318</PMID>
  </reference>
  <reference>
    <citation>Filipsson H, Johannsson G. GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. Eur J Endocrinol. 2009 Nov;161 Suppl 1:S85-95. doi: 10.1530/EJE-09-0319. Epub 2009 Aug 14. Review.</citation>
    <PMID>19684055</PMID>
  </reference>
  <reference>
    <citation>Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Biller BM, Monson JP, Stewart PM, Lennernäs H, Skrtic S. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab. 2012 Feb;97(2):473-81. doi: 10.1210/jc.2011-1926. Epub 2011 Nov 23.</citation>
    <PMID>22112807</PMID>
  </reference>
  <reference>
    <citation>Burger-Stritt S, Pulzer A, Hahner S. Quality of Life and Life Expectancy in Patients with Adrenal Insufficiency: What Is True and What Is Urban Myth? Front Horm Res. 2016;46:171-83. doi: 10.1159/000443918. Epub 2016 May 17. Review.</citation>
    <PMID>27211797</PMID>
  </reference>
  <reference>
    <citation>Stewart PM, Biller BM, Marelli C, Gunnarsson C, Ryan MP, Johannsson G. Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency. J Clin Endocrinol Metab. 2016 Dec;101(12):4843-4850. Epub 2016 Sep 13.</citation>
    <PMID>27623069</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2018</study_first_submitted>
  <study_first_submitted_qc>February 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2018</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary adrenal insufficiency</keyword>
  <keyword>Cardiovascular status</keyword>
  <keyword>Metabolic profile</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenal Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

